insights_auto
Outlook: 66.7% bullish·3.0% bearish
Go to analysischevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.४८
arrow_upward
+०.२४%(+०.००३५) 1D
नोभेम्बर १२, १४:४७:५१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.४४
High
US$ १.५३
Low
US$ १.३३
Mkt. cap
२७.६० करोड
Avg. vol.
१.९१ करोड
Volume
५६.१२ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१८.७३ करोड
No. of employees
११२
Open
US$ १.४४
High
US$ १.५३
Low
US$ १.३३
Mkt. cap
२७.६० करोड
Avg. vol.
१.९१ करोड
Volume
५६.१२ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१८.७३ करोड
No. of employees
११२
News stories
From web sources and news partners
GuruFocus
·
७ घण्टा पहिले
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlig
Yahoo Finance
·
१ दिन पहिले
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
TradingView
·
१ दिन पहिले
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Yahoo Finance
·
१ दिन पहिले
Inovio: Q3 Earnings Snapshot
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc